Focus: Turn Medical develops automated prone positioning systems for critically ill patients with respiratory distress, operating as an early-stage medical device/biotech company in the respiratory care space.
Profile data last refreshed 48m ago · AI intelligence enriched 2mo ago
Stable — net +1 jobs in 30d
2 added, 1 removed. Backfill posture.
This is a high-risk, high-reward early-stage opportunity best suited for mission-driven professionals with tolerance for uncertainty and appetite for equity-heavy compensation.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Core proprietary technology; pre-commercialization stage with no revenue yet reported.
Help build intelligence for Turn Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Turn Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo